These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30367253)

  • 21. An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: The microscale syntheses of nitrazolam and clonazolam for use as reference materials, utilizing polymer-supported reagents.
    Dowling G; Kavanagh PV; Eckhardt HG; Twamley B; Hessman G; McLaughlin G; O'Brien J; Brandt SD
    Drug Test Anal; 2018 Mar; ():. PubMed ID: 29542872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics.
    Moosmann B; Huppertz LM; Hutter M; Buchwald A; Ferlaino S; Auwärter V
    J Mass Spectrom; 2013 Nov; 48(11):1150-9. PubMed ID: 24259203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases.
    Heide G; Høiseth G; Middelkoop G; Øiestad ÅML
    J Anal Toxicol; 2020 Dec; 44(8):905-914. PubMed ID: 32369173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances.
    Wallach J; Brandt SD
    Handb Exp Pharmacol; 2018; 252():305-352. PubMed ID: 30196446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data.
    Partridge E; Trobbiani S; Stockham P; Charlwood C; Kostakis C
    J Anal Toxicol; 2018 Nov; 42(9):655-660. PubMed ID: 29945197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
    Batisse A; Eiden C; Peyriere H; Djezzar S;
    Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonazolam Intoxication Case Report: Danger of Designer Benzodiazepines.
    Moore C; Hammers J; Marshall P
    Am J Forensic Med Pathol; 2022 Dec; 43(4):372-375. PubMed ID: 36281064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel psychoactive substances.
    Krabseth HM; Tuv SS; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
    Tidsskr Nor Laegeforen; 2016 May; 136(8):714-7. PubMed ID: 27143461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synthetic cathinone α-pyrrolidinovalerophenone (α-PVP): pharmacokinetic and pharmacodynamic clinical and forensic aspects.
    Nóbrega L; Dinis-Oliveira RJ
    Drug Metab Rev; 2018 May; 50(2):125-139. PubMed ID: 29540067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens.
    Garland JM; Hull JD; Bender CL; Marshall L; Holt AC
    J Addict Med; 2022 May-Jun 01; 16(3):354-356. PubMed ID: 34172626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flubromazolam--A new life-threatening designer benzodiazepine.
    Łukasik-Głębocka M; Sommerfeld K; Teżyk A; Zielińska-Psuja B; Panieński P; Żaba C
    Clin Toxicol (Phila); 2016; 54(1):66-8. PubMed ID: 26585557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging Agents of Substance Use/Misuse.
    Michienzi AE; Borek HA
    Emerg Med Clin North Am; 2022 May; 40(2):265-281. PubMed ID: 35461623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes.
    Meyer MR; Bergstrand MP; Helander A; Beck O
    Anal Bioanal Chem; 2016 May; 408(13):3571-91. PubMed ID: 27071765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designer Drugs 2.0.
    Huestis MA; Tyndale RF
    Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designer benzodiazepines: an update.
    Yu X; Greenblatt HK; Greenblatt DJ
    Expert Rev Clin Pharmacol; 2023 Feb; 16(2):109-117. PubMed ID: 36649662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deconstructing Designer Drugs.
    Sellers EM
    Clin Pharmacol Ther; 2017 Feb; 101(2):167-169. PubMed ID: 27564430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.